Michael Belshan

Affiliations: 
Medical Microbiology and Immunology Creighton University, Omaha, NE, United States 
Area:
Immunology, Microbiology Biology, Cell Biology
Google:
"Michael Belshan"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mandal S, Sunagawa SW, Prathipati PK, et al. (2022) Targeted Immuno-Antiretroviral to Promote Dual Protection against HIV: A Proof-of-Concept Study. Nanomaterials (Basel, Switzerland). 12
Macur K, Zieschang S, Lei S, et al. (2021) SWATH-MS and MRM: Quantification of Ras-related proteins in HIV-1 infected and methamphetamine-exposed human monocyte-derived macrophages (hMDM). Proteomics. e2100005
Belshan M, Holbrook A, George JW, et al. (2021) Discovery of candidate HIV-1 latency biomarkers using an OMICs approach. Virology. 558: 86-95
Holbrook AK, Peterson HD, Bianchi SA, et al. (2019) CD4 T cell activation and associated susceptibility to HIV-1 infection in vitro increased following acute resistance exercise in human subjects. Physiological Reports. 7: e14234
Mandal S, Prathipati PK, Belshan M, et al. (2019) A potential long-acting bictegravir loaded nano-drug delivery system for HIV-1 infection: A proof-of-concept study. Antiviral Research
DeBoer J, Wojtkiewicz MS, Haverland N, et al. (2018) Proteomic profiling of HIV-infected T-cells by SWATH mass spectrometry. Virology. 516: 246-257
Holbrook AK, Belshan MA, Bredahl EC, et al. (2018) The Effect Of Exercise On CD4+ T-cell Activation And Their Susceptibility To HIV-1 Medicine & Science in Sports & Exercise. 50: 224
Mandal S, Belshan M, Holec A, et al. (2016) An enhanced Emtricitabine loaded long-acting nano-formulation for prevention or treatment of HIV infection. Antimicrobial Agents and Chemotherapy
Li Y, Belshan M. (2016) NF45 and NF90 Bind HIV-1 RNA and Modulate HIV Gene Expression. Viruses. 8
DeBoer J, Madson CJ, Belshan M. (2016) Cyclophilin B enhances HIV-1 infection. Virology. 489: 282-91
See more...